To address whether IL-1β signal plays a role in stroke onset in SHRSP with severe hypertension, SHRSP underwent continuous administration of IL-1β (2 μg/day) using an osmotic pump for 4 weeks. This evidence concerns the gene IL1B and hypertensive disorder.